Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™

CompletedOBSERVATIONAL
Enrollment

1,524

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix

Trial Locations (12)

2257

GSK Investigational Site, Umina

2606

GSK Investigational Site, Garran

3050

GSK Investigational Site, Parkville

3084

GSK Investigational Site, Heidelberg Heights

3168

GSK Investigational Site, Clayton

4021

GSK Investigational Site, Kippa-Ring

4066

GSK Investigational Site, Auchenflower

4101

GSK Investigational Site, South Brisbane

6009

GSK Investigational Site, Nedlands

Unknown

GSK Investigational Site, Hobart

80810-050

GSK Investigational Site, Curitiba/Paraná

04020050

GSK Investigational Site, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY